About Jill

This author has not yet filled in any details.
So far Jill has created 44 blog entries.

MHRA (GxP) Inspections during COVID19

2020-10-12T13:20:44+01:00

The COVID19 pandemic presents an unprecedented challenge to healthcare, the pharmaceutical industry’s supply chain and personnel movement. MHRA understands the impact of its work on industry, NHS and patients. This is not just in terms of our regulatory support to bring new technologies and products quickly and safely to market, but also [...]

MHRA (GxP) Inspections during COVID192020-10-12T13:20:44+01:00

Regulations for Pharmaceuticals Post Brexit

2020-10-12T13:43:15+01:00

The European Commission has published a Communication to prepare for the end of the transition period. The document is appropriately entitled "Getting ready for changes - Communication on readiness at the end of the transition period between the European Union and the United Kingdom". Far-reaching changes and consequences are therefore to be [...]

Regulations for Pharmaceuticals Post Brexit2020-10-12T13:43:15+01:00

Complying with new GDP requirements

2020-10-01T14:34:12+01:00

In an ever changing and complex industry the role of the Responsible Person has developed and grown over the past 10 years as the focus of regulatory bodies have placed a higher level of scrutiny on how GDP principals are implemented and applied for Wholesale Distributors. Initially the main areas of compliance [...]

Complying with new GDP requirements2020-10-01T14:34:12+01:00

QP Responsibilities

2020-09-29T16:00:24+01:00

MIAS Pharma provides QP services for commercial and investigational medicinal products. Our QPs have experience in oversight and release of multiple types of products. Each type of product has it's own specific properties and challenges, which determines what approach should be taken to provide the best solutions. Sterile products have to be [...]

QP Responsibilities2020-09-29T16:00:24+01:00

Pharma Industry Awards 2020

2020-09-21T13:08:49+01:00

We’re pleased to announce that MIAS Pharma Ltd has been shortlisted for Pharma Supplier of the Year in this years Pharma Industry awards. We look forward to a great evening and catching up with our peers and suppliers. Since launching in 2014, the Pharma Industry Awards has established itself as the benchmark for those [...]

Pharma Industry Awards 20202020-09-21T13:08:49+01:00

A Message from MIAS Pharma (COVID – 19)

2020-04-07T14:15:30+01:00

I wish to update you on MIAS Pharma ltd position regarding COVID-19. The World Health Organisation formally declared COVID-19 a pandemic, and the European Centre for Disease Prevention and Control (ECDC) updated its guidelines around the importance of early intervention. While continuing to conduct business in these challenging times it is our priority to reduce [...]

A Message from MIAS Pharma (COVID – 19)2020-04-07T14:15:30+01:00

Good Distribution Practice (GDP): Issue of Theft

2019-09-24T14:56:53+01:00

The wholesale distribution of medicinal products and active substances is an important activity. The quality and the integrity of medicinal products can be affected by a lack of adequate control. The quality, safety and efficacy of medicinal products depend on a whole range of different factors. The most important factors are that [...]

Good Distribution Practice (GDP): Issue of Theft2019-09-24T14:56:53+01:00

Pharma giant tackling counterfeit drugs using blockchain

2019-09-19T12:02:36+01:00

Fighting counterfeit drugs with blockchain technology… The Asia-Pacific pharmaceutical giant Zuellig pharma is using a blockchain platform by SAP to assist consumers identify the medicines place of origin. With 1 in 10 medicinal products that are used in developing countries deemed fake, there is a substantial need to eradicate counterfeit drugs that [...]

Pharma giant tackling counterfeit drugs using blockchain2019-09-19T12:02:36+01:00

Brexit Preparedness Checklist – HPRA

2019-09-17T13:44:34+01:00

The Health Products Regulatory Authority (HPRA) have released a 'Brexit Preparedness' checklist. The checklist has been divided into four parts which include:  Supply Chain  Customs  Medicines Regulatory Compliance Medical Devices Supply Chain In relation to the supply of medicines and medical devices, companies are requested to: Map your supply chain to [...]

Brexit Preparedness Checklist – HPRA2019-09-17T13:44:34+01:00

EU: First steps taken to diminish drug shortages

2019-09-10T09:55:50+01:00

Regulators in the European Union (EU) have began taking the first steps reduce shortages of medicinal products. The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) recently published two guidance documents. The two guidance documents are said to be used as a foundation. The first guidance document that has [...]

EU: First steps taken to diminish drug shortages2019-09-10T09:55:50+01:00
Go to Top